Department of Epidemiology & Biostatistics, University of Georgia, Athens, Georgia.
University of Basel, Basel, Switzerland.
Am J Trop Med Hyg. 2019 Dec;101(6):1336-1344. doi: 10.4269/ajtmh.19-0273.
The WHO recommends mass treatment with praziquantel as the primary approach for -related morbidity control in endemic populations. The Schistosomiasis Consortium for Operational Research and Evaluation implemented multi-country, cluster-randomized trials to compare effectiveness of community-wide and school-based treatment (SBT) regimens on prevalence and intensity of schistosomiasis. To assess the impact of two different treatment schedules on -associated morbidity in children, cohort studies were nested within the randomized trials conducted in villages in Kenya and Tanzania having baseline prevalence ≥ 25%. Children aged 7-8 years were enrolled at baseline and followed to ages 11-12 years. Infection intensity and odds of infection were reduced both in villages receiving four years of annual community-wide treatment (CWT) and those who received biennial SBT over 4 years. These regimens were also associated with reduced odds of undernutrition and reduced odds of portal vein dilation at follow-up. However, neither hemoglobin levels nor the prevalence of the rare abnormal pattern C liver scores on ultrasound improved. For the combined cohorts, growth stunting worsened in the areas receiving biennial SBT, and maximal oxygen uptake as estimated by fitness testing scores declined under both regimens. After adjusting for imbalance in starting prevalence between study arms, children in villages receiving annual CWT had significantly greater decreases in infection prevalence and intensity than those villages receiving biennial SBT. Although health-related quality-of-life scores improved in both study arms, children in the CWT villages gained significantly more. We conclude that programs using annual CWT are likely to achieve better overall morbidity control than those implementing only biennial SBT.
世界卫生组织建议采用大规模吡喹酮治疗作为控制流行地区与血吸虫病相关发病率的主要方法。血吸虫病合作研究与评价实施了多国、群组随机试验,以比较社区范围和学校为基础的治疗(SBT)方案对血吸虫病流行率和强度的效果。为了评估两种不同治疗方案对儿童相关发病率的影响,在肯尼亚和坦桑尼亚的村庄中进行的群组随机试验中嵌套了队列研究,这些村庄的基线流行率≥25%。7-8 岁的儿童在基线时入组,并随访至 11-12 岁。在接受四年年度社区范围治疗(CWT)的村庄和接受四年双年度 SBT 的村庄中,感染强度和感染的几率都降低了。这两种方案还与营养不良的几率降低和随访时门静脉扩张的几率降低相关。然而,血红蛋白水平或超声上罕见的异常 C 型肝评分的流行率都没有改善。对于合并队列,接受双年度 SBT 的地区的生长迟缓恶化,两种方案下的最大摄氧量(通过体能测试评分估计)都下降。在校正研究臂之间起始流行率的不平衡后,接受年度 CWT 的村庄中的儿童的感染流行率和强度下降幅度显著大于接受双年度 SBT 的村庄。尽管两个研究臂的健康相关生活质量评分都有所提高,但 CWT 村庄的儿童获得的改善更为显著。我们的结论是,采用年度 CWT 的方案可能比仅实施双年度 SBT 的方案更能实现整体发病率的更好控制。